Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort

AIM: To examine patient-centered outcomes with vasopressin (AVP) use in patients with cirrhosis with catecholamine-refractory septic shock. METHODS: We conducted a single center, retrospective cohort study enrolling adult patients with cirrhosis treated for catecholamine-resistant septic shock in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Myc, Lukasz A, Stine, Jonathan G, Chakrapani, Rinita, Kadl, Alexandra, Argo, Curtis K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241528/
https://www.ncbi.nlm.nih.gov/pubmed/28144392
http://dx.doi.org/10.4254/wjh.v9.i2.106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241528/
https://www.ncbi.nlm.nih.gov/pubmed/28144392
http://dx.doi.org/10.4254/wjh.v9.i2.106

Ejemplares similares